[Emerging notions about the microenvironmental control of tumor growth and dissemination]

Sylvain Provot1

  • 1UMR 1132, université Paris Diderot, centre Viggo Petersen-hôpital Lariboisière, 2, rue Ambroise Paré, 75010 Paris, France.

Medecine Sciences : M/S
|May 8, 2014
PubMed

Insights

Cancer therapies often fail because they ignore the tumor microenvironment. Understanding how cancer cells and their surroundings interact is key to developing more effective treatments.

Area of Science:

  • Oncology
  • Cancer Biology
  • Tumor Microenvironment Research

Context:

  • Despite advances in understanding neoplastic transformation, cancer therapies show limited efficacy.
  • The tumor microenvironment (TME) plays a critical role in tumor progression and treatment resistance.

Purpose:

  • To review the current understanding of interactions between cancer cells and their microenvironment.
  • To highlight the local and systemic effects of these interactions.

Summary:

  • Neoplastic cells dynamically interact with their surrounding microenvironment.
  • These interactions influence tumor growth, metastasis, and response to therapy.
  • The TME encompasses cellular and non-cellular components that modulate cancer progression.

Impact:

  • Provides insights into novel therapeutic strategies targeting the tumor microenvironment.
  • Enhances understanding of treatment resistance mechanisms.
  • Facilitates the development of more effective and durable cancer therapies.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

2.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K